From genetics to the clinic: a translational perspective on follicular lymphoma. (Q50107045)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

title

From genetics to the clinic: a translational perspective on follicular lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Sarah Huet

1 reference

15 March 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

Pierre Sujobert

series ordinal

object named as

Pierre Sujobert

1 reference

15 March 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

language of work or name

English

0 references

publication date

9 February 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

224-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

Germinal centres and B cell lymphomagenesis

15 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Dynamics of B cells in germinal centres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Early steps of follicular lymphoma pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma: evolving therapeutic strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

A meta-analysis of genome-wide association studies of follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The tumour microenvironment in B cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Involvement of the bcl-2 gene in human follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genomic Architecture may Influence Recurrent Chromosomal Translocation Frequency in the Igh Locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Refinement of theBCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Germinal centers in human lymph nodes contain reactivated memory B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Multiple layers of B cell memory with different effector functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Different B cell populations mediate early and late memory during an endogenous immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Nature and importance of follicular lymphoma precursors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

In situ localization of follicular lymphoma: description and analysis by laser capture microdissection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Early lesions of follicular lymphoma: a genetic perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

EZH2 mutations are frequent and represent an early event in follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The many layers of epigenetic dysfunction in B-cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genetics of follicular lymphoma transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Whole-genome fingerprint of the DNA methylome during human B cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Array-based DNA methylation profiling in follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genomic and epigenomic co-evolution in follicular lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mechanisms of B-cell lymphoma pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Targeting pathological B cell receptor signalling in lymphoid malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Self-antigen recognition by follicular lymphoma B-cell receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma (FL): Immunological tolerance theory in FL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Oncogenic CARD11 Mutations Induce Hyperactive Signaling by Disrupting Autoinhibition by the PKC-Responsive Inhibitory Domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Targeting of B-cell receptor signalling in B-cell malignancies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Activating STAT6 mutations in follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Notch as a tumour suppressor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

mTOR: from growth signal integration to cancer, diabetes and ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Regulation of TORC1 by Rag GTPases in nutrient response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

m-TOR inhibitors and their potential role in haematological malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The sphingosine 1-phosphate receptor S1P₂ maintains the homeostasis of germinal center B cells and promotes niche confinement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Balancing co-stimulation and inhibition with BTLA and HVEM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Cell of origin of transformed follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

S(mu) mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

EZH2 alterations in follicular lymphoma: biological and clinical correlations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Can histologic transformation of follicular lymphoma be predicted and prevented?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Liquid biopsies come of age: towards implementation of circulating tumour DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Integrated digital error suppression for improved detection of circulating tumor DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Are we nearing an era of chemotherapy-free management of indolent lymphoma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Chemotherapy-free treatment in patients with follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The concept of synthetic lethality in the context of anticancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Non-oncogene addiction and the stress phenotype of cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Roles of BCL6 in normal and transformed germinal center B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.127

Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals

31 March 2020

1 reference

12 December 2020

p53 mutation is associated with progression in follicular lymphomas

1 reference

12 December 2020

p53 mutations are associated with histologic transformation of follicular lymphoma

1 reference

12 December 2020

p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas

1 reference

12 December 2020

DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma

1 reference

12 December 2020

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC.2017.127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29422597%20AND%20SRC:MED&resulttype=core&format=json